VeriMomcoptis japonica rhizome extract hamilelikte güvenli mi?
Coptis japonica rhizome extract (CAS 223748-66-1) is listed in the EU cosmetic ingredients list (Cosmetic Directive publication) as a permitted botanical extract with no Annex II ban or Annex III restriction; no harmonised CLP reproductive (H360/H361) or CMR classification was found. Large epidemiology on related Coptis/Coptidis rhizoma used orally showed no clear adverse effect on fetal growth at usual use, and mutagenicity testing of Coptis rhizome extracts did not indicate strong genotoxicity across standard assays. Given lack of reproductive/teratogenic animal or harmonised hazard data, hazard (h) and mechanism (m) are scored 0. Topical exposure is scored as low but measurable (e=1) because botanical extracts can deliver small amounts of phytochemicals through skin but no specific dermal absorption data were found.
Related ingredients
Frequently asked questions
- coptis japonica rhizome extract hamilelikte güvenli mi?
- Coptis japonica rhizome extract (CAS 223748-66-1) is listed in the EU cosmetic ingredients list (Cosmetic Directive publication) as a permitted botanical extract with no Annex II ban or Annex III restriction; no harmonised CLP reproductive (H360/H361) or CMR classification was found. Large epidemiology on related Coptis/Coptidis rhizoma used orally showed no clear adverse effect on fetal growth at usual use, and mutagenicity testing of Coptis rhizome extracts did not indicate strong genotoxicity across standard assays. Given lack of reproductive/teratogenic animal or harmonised hazard data, hazard (h) and mechanism (m) are scored 0. Topical exposure is scored as low but measurable (e=1) because botanical extracts can deliver small amounts of phytochemicals through skin but no specific dermal absorption data were found.
- coptis japonica rhizome extract emzirirken güvenli mi?
- No evidence of a reproductive or lactation hazard, no harmonised classifications, and no human data showing transfer via breastmilk for cosmetic topical use. Exposure considered low but measurable (e=1) for adult topical use in absence of dermal absorption data.
- coptis japonica rhizome extract bebek cildi için güvenli mi?
- No infant-specific toxicity or developmental hazards were identified. Per scoring rules, exposure for 0–3 yr skin is increased by +1 over adult when the ingredient has measurable absorption: adult e=1 → baby e=2. There is no direct evidence to increase hazard (h) or mechanism (m) for infants.
- VeriMom coptis japonica rhizome extract nasıl puanlıyor?
- VeriMom coptis japonica rhizome extract'yi EU CosIng, ECHA sınıflandırmaları ve PubMed çalışmalarına göre 93/100 (bilinen risk yok) olarak puanlar.
- Hamilelikte coptis japonica rhizome extract yerine neler kullanılabilir?
- Benzer işlevli ve bilinen riski olmayan alternatifleri içeren listemize bakın.
Her etiketi 2 saniyede kontrol et
VeriMom'u ücretsiz indirin — herhangi bir ürünü tarayın ve hamilelik güvenlik puanını anında görün.
Tıbbi Sorumluluk Reddi
Bu bilgiler yalnızca eğitim amaçlıdır ve tıbbi tavsiye niteliği taşımaz. Güvenlik puanları kamuya açık verilere dayanmaktadır ve tüm riskleri yansıtmayabilir. Hamilelik veya emzirme döneminde herhangi bir ürünü kullanmadan önce her zaman sağlık uzmanınıza danışın.